Diuretic-induced hypokalemia may enhance neuromuscular blocking effects, potentially causing respiratory depression or apnea.
Source: NLP:metolazone
14 interactions on record
Diuretic-induced hypokalemia may enhance neuromuscular blocking effects, potentially causing respiratory depression or apnea.
Source: NLP:metolazone
D-tubocurarine and vecuronium may manifest additive neuromuscular blocking effects when used together due to similar mechanism of action.
Source: NLP:vecuronium bromide
Possible increased responsiveness to nondepolarizing skeletal muscle relaxants when used with hydrochlorothiazide.
Source: NLP:amiloride hydrochloride and hydrochlorothiazide
Amphotericin B-induced hypokalemia may enhance the curariform effect of skeletal muscle relaxants. Serum potassium levels should be closely monitored.
Source: NLP:amphotericin b
Thiazides may increase responsiveness to tubocurarine.
Source: NLP:atenolol and chlorthalidone
Possible increased responsiveness to tubocurarine may occur when used concurrently with chlorothiazide.
Source: NLP:chlorothiazide
Possible increased responsiveness to tubocurarine when used concurrently with chlorothiazide sodium.
Source: NLP:chlorothiazide sodium
Chlorthalidone may increase the responsiveness to tubocurarine, potentially enhancing its neuromuscular blocking effects.
Source: NLP:chlorthalidone
Furosemide may antagonize the skeletal muscle relaxing effect of tubocurarine.
Source: NLP:furosemide
Possible increased responsiveness to the muscle relaxant may occur.
Source: NLP:hydrochlorothiazide
Tubocurarine-type muscle relaxants may potentiate the effect of incobotulinumtoxina. Co-administer only with caution and close observation.
Source: NLP:incobotulinumtoxina
Possible increased responsiveness to the nondepolarizing muscle relaxant may result.
Source: NLP:spironolactone
Possible increased responsiveness to the muscle relaxant may result.
Source: NLP:spironolactone and hydrochlorothiazide
Thiazides have been shown to increase responsiveness to tubocurarine.
Source: NLP:triamterene and hydrochlorothiazide